| |
|
|
|
Market Wire - Computers and Software |
Mon, 18 Jul 2005 23:00:00 PDT |
|
|
OmniComm Systems, Inc.: CINRG Awards OmniComm Additional Clinical Trials |
|
FORT LAUDERDALE, FL (MARKET WIRE) OmniComm Systems, Inc. (OTC BB: OMCM), one of the fastest growing companies in the EDC marketplace, is pleased to announce that CINRG, the Cooperative International Neuromuscular Research Group, has once again chosen OmniComm's TrialMaster(R) EDC solution to support two critical upcoming Phase III studies. CINRG is the clinical research arm of the Duchenne Muscular Dystrophy Research Center ("DMDRC"), |
|
[ read complete story ]
|
|
|
|
|
